cbdMD Inc. [AMEX: YCBD] price plunged by -5.33 percent to reach at -$0.17. The company report on August 14, 2020 that MMA Champion Daniel Cormier Trusts cbdMD To Prepare for the Fight of His Career.
cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading and most highly trusted and recognized cannabidiol (CBD) brands, is proud to support MMA champion Daniel “DC” Cormier, a premier member of “Team cbdMD”, which is the CBD industry’s premier athletic sponsorship program, as he prepares for the fight of his career. This Saturday, August 15, 2020, Cormier is slated to headline a primetime MMA showdown against heavyweight champ Stipe Miocic in a highly anticipated ‘rubber match’. ‘Miocic vs. Cormier 3’ will air live at 10 PM ET (ESPN+ PPV) from the UFC APEX facility in Las Vegas.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200814005431/en/.
A sum of 1280755 shares traded at recent session while its average daily volume was at 2.21M shares. cbdMD Inc. shares reached a high of $3.19 and dropped to a low of $2.85 until finishing in the latest session at $3.02.
The one-year YCBD stock forecast points to a potential upside of 37.99. The average equity rating for YCBD stock is currently 2.30, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on cbdMD Inc. [YCBD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for YCBD shares is $4.87 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on YCBD stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for cbdMD Inc. is set at 0.32, with the Price to Sales ratio for YCBD stock in the period of the last 12 months amounting to 4.35. The Price to Book ratio for the last quarter was 1.85, with the Price to Cash per share for the same quarter was set at 0.27.
YCBD Stock Performance Analysis:
cbdMD Inc. [YCBD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -23.35. With this latest performance, YCBD shares gained by 11.03% in over the last four-week period, additionally plugging by 160.34% over the last 6 months – not to mention a drop of -29.27% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for YCBD stock in for the last two-week period is set at 49.96, with the RSI for the last a single of trading hit 41.00, and the three-weeks RSI is set at 54.10 for cbdMD Inc. [YCBD]. The present Moving Average for the last 50 days of trading for this stock 2.50, while it was recorded at 3.31 for the last single week of trading, and 1.88 for the last 200 days.
Insight into cbdMD Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and cbdMD Inc. [YCBD] shares currently have an operating margin of -60.72 and a Gross Margin at +61.37. cbdMD Inc.’s Net Margin is presently recorded at -192.08.
Return on Total Capital for YCBD is now -55.64, given the latest momentum, and Return on Invested Capital for the company is -180.95. Return on Equity for this stock declined to -180.95, with Return on Assets sitting at -82.95.
Reflecting on the efficiency of the workforce at the company, cbdMD Inc. [YCBD] managed to generate an average of -$249,614 per employee. Receivables Turnover for the company is 6.88 with a Total Asset Turnover recorded at a value of 0.43.cbdMD Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.00 and a Current Ratio set at 5.50.
YCBD Stock EPS
With the latest financial reports released by the company, cbdMD Inc. posted 0.79/share EPS, while the average EPS was predicted by analysts to be reported at -0.17/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 564.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for YCBD.
cbdMD Inc. [YCBD] Insider Position Details
There are presently around $15 million, or 14.40% of YCBD stock, in the hands of institutional investors. The top three institutional holders of YCBD stocks are: VANGUARD GROUP INC with ownership of 1,223,882, which is approximately -6.096% of the company’s market cap and around 0.80% of the total institutional ownership; MIRAE ASSET GLOBAL INVESTMENTS CO., LTD., holding 687,257 shares of the stock with an approximate value of $2.08 million in YCBD stocks shares; and BLACKROCK INC., currently with $1.7 million in YCBD stock with ownership of nearly -61.496% of the company’s market capitalization.
Positions in cbdMD Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 29 institutional holders increased their position in cbdMD Inc. [AMEX:YCBD] by around 1,451,627 shares. Additionally, 34 investors decreased positions by around 3,325,198 shares, while 7 investors held positions by with 287,405 shares. The mentioned changes placed institutional holdings at 5,064,230 shares, according to the latest SEC report filing. YCBD stock had 18 new institutional investments in for a total of 537,119 shares, while 20 institutional investors sold positions of 1,282,564 shares during the same period.